Skip to main content
Maryam Valapour, MD, Pulmonology, Cleveland, OH, Cleveland Clinic

MaryamValapourMDMPP

Pulmonology • Cleveland, OH

Lung Transplantation Medicine

Director, Lung Transplant Outcomes Research

Join to view full profile

Dr. Valapour is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Valapour's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2002
  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1995 - 1998
  • Medical University of South Carolina
    Medical University of South CarolinaClass of 1995

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2014 - 2025
  • MN State Medical License
    MN State Medical License 2003 - 2015
  • PA State Medical License
    PA State Medical License 1996 - 2002
  • MD State Medical License
    MD State Medical License 1998 - 2001
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Fellow American Society of Transplantation (FAST), 2019
  • Champion of Care University of Minnesota, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Heart Transplantation: An In-Depth Survival Analysis.  
    Hsich, E. M., Blackstone, E. H., Thuita, L. W., McNamara, D. M., Rogers, J. G., Yancy, C. W., Goldberg, L. R., Valapour, M., Xu, G., & Ishwaran, H., JACC: Heart Failure, 2020
  • The impact of change in definition of increased-risk donors on survival after lung transplant.  
    Lehr, C. J., Lopez, R., Arrigain, S., Schold, J., Koval, C., & Valapour, M., The Journal of thoracic and cardiovascular surgery,, 2020
  • OPTN/SRTR 2018 Annual Data Report: Lung.  
    Valapour, M., Lehr, C. J., Skeans, M. A., Smith, J. M., Uccellini, K., Goff, R., Foutz, J., Israni, A. K., Snyder, J. J., & Kasiske, B. L., American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2020
  • Join now to see all

Press Mentions

  • Adding Clinical Variables Improves Accuracy of Lung Allocation Score
    Adding Clinical Variables Improves Accuracy of Lung Allocation ScoreJune 25th, 2019
  • Record Number of Lung Transplants Performed in the U.S. In 2017
    Record Number of Lung Transplants Performed in the U.S. In 2017April 17th, 2019
  • Identifying Lung Cancer Risk Factors in Lung Transplant Recipients
    Identifying Lung Cancer Risk Factors in Lung Transplant RecipientsMarch 18th, 2019
  • Join now to see all

Grant Support

  • CF Lung Transplant Consortium Biorepository Coordinating CenterCystic Fibrosis Foundation2020–2025
  • Scientific Registry of Transplant RecipientsDHHS, Health Resources and Services Administration2010–2025
  • Forecasting Lung Transplant Benefit: A Dynamic Risk Modeling ApproachNational Institutes of Health/ National Heart, Lung, and Blood Institute2020–2024
  • CF Lung Transplant Transition Leadership Learning CooperativeCystic Fibrosis Foundation2020–2023
  • Cystic Fibrosis Lung Transplant ConsortiumCystic Fibrosis Foundation2020–2023
  • Impact of Disparities Affecting Survival among Advanced Heart Failure Patients and Transplant RecipientsNational Institutes of Health/ National Heart, Lung, and Blood Institute2018–2023
  • Improving Predictive Accuracy of the Lung Allocation Score for CF PatientsCystic Fibrosis Foundation2019–2022
  • CF Lung Transplant Transition Leadership Learning CooperativeCystic Fibrosis Foundation2017–2020
  • Cystic Fibrosis Lung Transplant ConsortiumCystic Fibrosis Foundation2017–2020
  • Impact of Pre- and Post-Transplant T Cell Alloreactivity on Lung TransplantCystic Fibrosis Foundation2016–2020
  • Clinical Center – Outcomes of Live Organ DonorsNIH/NHLBI-NIAID2006–2014
  • Designing Fair and Effective Organ Transplant Allocation SystemsMinnesota Medical Foundation2009–2011
  • Understanding Barriers To Living Donor Lung TransplantationNational Heart, Lung, And Blood Institute2007–2010
  • Understanding Barriers To Living Donor Lung TransplantatNational Heart, Lung, And Blood Institute2006

Professional Memberships

Hospital Affiliations

Dr. Maryam Valapour, Dr. Maryam Valapour, MD, Dr. M Valapour